1-4 of 4
Christian Thiede
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TERT Promoter Mutation Detection in Cell-Free Tumor-Derived DNA in Patients with IDH Wild-Type Glioblastomas: A Pilot Prospective Study

Tareq A. Juratli, Sebastian Stasik, Amir Zolal, Caroline Schuster, Sven Richter, Dirk Daubner, Mazen A. Juratli, Rachel Thowe, Silke Hennig, Meriem Makina, Matthias Meinhardt, Tim Lautenschlaeger, Gabriele Schackert, Dietmar Krex, Christian Thiede
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (21): 5282–5291.
https://doi.org/10.1158/1078-0432.CCR-17-3717
Published: 01 November 2018
View article titled, <em>TERT</em> Promoter Mutation Detection in Cell-Free Tumor-Derived DNA in Patients with <em>IDH</em> Wild-Type Glioblastomas: A Pilot Prospective Study
Open the PDF for <em>TERT</em> Promoter Mutation Detection in Cell-Free Tumor-Derived DNA in Patients with <em>IDH</em> Wild-Type Glioblastomas: A Pilot Prospective Study in another window
Includes: Supplementary data
Journal Articles

Gemtuzumab Ozogamicin as Part of Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed Acute Myeloid Leukemia

Martin Bornhäuser, Thomas Illmer, Uta Oelschlaegel, Johannes Schetelig, Rainer Ordemann, Markus Schaich, Mathias Hänel, Ulrich Schuler, Christian Thiede, Alexander Kiani, Uwe Platzbecker, Gerhard Ehninger
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (17): 5585–5593.
https://doi.org/10.1158/1078-0432.CCR-08-0894
Published: 02 September 2008
View article titled, Gemtuzumab Ozogamicin as Part of Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed Acute Myeloid Leukemia
Open the PDF for Gemtuzumab Ozogamicin as Part of Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed Acute Myeloid Leukemia in another window
Journal Articles

Activation of the RAS Pathway Is Predictive for a Chemosensitive Phenotype of Acute Myelogenous Leukemia Blasts

Thomas Illmer, Christian Thiede, Anke Fredersdorf, Sylvia Stadler, Andreas Neubauer, Gerhard Ehninger, Markus Schaich
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (9): 3217–3224.
https://doi.org/10.1158/1078-0432.CCR-04-2232
Published: 02 May 2005
View article titled, Activation of the <em>RAS</em> Pathway Is Predictive for a Chemosensitive Phenotype of Acute Myelogenous Leukemia Blasts
Open the PDF for Activation of the <em>RAS</em> Pathway Is Predictive for a Chemosensitive Phenotype of Acute Myelogenous Leukemia Blasts in another window
Journal Articles

Dose-reduced Conditioning and Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Donors in 42 Patients

Martin Bornhäuser, Christian Thiede, Uwe Platzbecker, Andreas Jenke, Anett Helwig, Runa Plettig, Jens Freiberg-Richter, Christoph Röllig, Gabriele Geissler, Karin Lutterbeck, Uta Oelschlagel, Gerhard Ehninger
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (8): 2254–2262.
Published: 01 August 2001
View article titled, Dose-reduced Conditioning and Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Donors in 42 Patients
Open the PDF for Dose-reduced Conditioning and Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Donors in 42 Patients in another window